Similar articles

• [Non-viral fulminant hepatitis].

  Pageaux GP. Pageaux GP. Gastroenterol Clin Biol. 2003 May;27(5 Suppl):B137-9. Gastroenterol Clin Biol. 2003. PMID: 12843947 French. No abstract available.
• Assessment of drug-induced liver injury in clinical practice.

  Lucena MI, García-Cortés M, Cueto R, Lopez-Duran J, Andrade RJ. Lucena MI, et al. Fundam Clin Pharmacol. 2008 Apr;22(2):141-58. doi: 10.1111/j.1472-8206.2008.00566.x. Fundam Clin Pharmacol. 2008. PMID: 18353109 Review.
• [Carefully reviewing the history of diagnostic scales and paying more attention to the diagnostic value of Roussel - Uclaf causality assessment method scale for drug - induced liver injury].

  Chen CW. Chen CW. Zhonghua Gan Zang Bing Za Zhi. 2016 Nov 20;24(11):801-803. doi: 10.3760/cma.j.issn.1007-3418.2016.11.001. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 27978922 Review. Chinese.
• Patient health questionnaire. Using a patient-focused assessment tool.

  Mitchell JD. Mitchell JD. Can Fam Physician. 1996 Mar;42:505-11. Can Fam Physician. 1996. PMID: 8616290 Free PMC article.
• [Acute toxic hepatitis: RUCAM application to drug-induced liver injury and its limitations].

  Ahn BM. Ahn BM. Korean J Hepatol. 2006 Mar;12(1):1-4. Korean J Hepatol. 2006. PMID: 16565601 Korean. No abstract available.